Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth.
The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day program 6th Annual Pharma Manufacturing and Automation Convention 2024.
The FDA broadened the uses of Insulet SmartAdjust, a technology for diabetes management, to include type 2 diabetes in adults over 18 years old, in addition to type 1 diabetes in individuals aged two and older. Software that automatically adjusts...
On Tuesday, Bharat Biotech announced that its oral cholera vaccine has successfully completed a late-stage trial and is preparing for a global launch, with plans to produce up to 200 million doses annually. The vaccine, named Hillchol, has receive...
Alembic Pharmaceuticals announced on Monday that it has received approval from the US Food & Drug Administration (USFDA) to market a generic version of Betamethasone Valerate Foam, a medication used to treat moderate-to-severe psoriasis of the scalp.
Alkermes plc has commenced the Vibrance-2 study, which is a phase 2 clinical trial assessing the safety and effectiveness of ALKS 2680 versus placebo in adult patients with narcolepsy type 2 (NT2). ALKS 2680 is a new, under investigation, oral...
Sun Pharmaceutical Industries Limited introduced tedizolid phosphate tablets 200 mg in India with the brand name "Starizo". Starizo (tedizolid phosphate) is a new antibiotic in the oxazolidinone class, prescribed for acute bacterial skin and skin...
Alkem Laboratories has become the first Indian pharmaceutical company to venture into medical devices, following a partnership with US-based Exactech to produce and market its joint replacement implants in India. Through this agreement, Exactech, ...
Pristyn Care, a top player in follow-up surgeries in India, has launched the Innovation Lab, a specialized program aiming to foster progress in AI in the healthcare industry. It will offer AI startups in their early stages a special opportunity...
Adar Poonawalla, CEO of Serum Institute of India (SII), has announced that the company is working on developing a vaccine for Mpox, with expectations of a "positive outcome" within a year. This development comes in response to the global Mpox outb...
, CDSCO.jpg)
.jpg)